PharmaEssentia GDS Issuance - Strong Revenue Growth and Narrowing Losses

954 Views13 Apr 2023 19:39

Pharmaessentia Corp (6446 TT) aims to raise around US$412m (TWD12.6bn) via a GDS issuance. In this note, we will talk about the deal dynamics and run the deal through our ECM framework.

SUMMARY

(Sign Up to Access)

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Full Insight

(Paid Plans Only, 4-minute read)

Discussions

(Paid Plans Only)

Rising

Ethan Aw

APAC IPOs & Placements

Aequitas Research

EquitiesEquity Capital Markets

View Full Profile

Price Chart(Sign Up to Access)

Insight Stream